VSMD Stock Overview

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. More details

VSMD fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($8)

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

Vasamed, Inc. Competitors

Minerva Surgical

OTCPK:UTRS

US$887.0

Motus GI Holdings

OTCPK:MOTS

US$719.0

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ETAO International

OTCPK:ETAO.F

US$5.0

Price History & Performance

Summary of share price highs, lows and changes for Vasamed
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-99.99%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	VSMD	US Medical Equipment	US Market
7D	0%	-1.5%	-2.4%
1Y	n/a	10.1%	23.3%

Return vs Industry: Insufficient data to determine how VSMD performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how VSMD performed against the US Market.

Price Volatility

Is VSMD's price volatile compared to industry and market?
VSMD volatility
VSMD Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: VSMD's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine VSMD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1988	n/a	Mike Schreiber	www.vasamed.com

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system.

Vasamed, Inc. Fundamentals Summary

How do Vasamed's earnings and revenue compare to its market cap?
VSMD fundamental statistics
Market cap	US$8.00
Earnings (TTM)	-US$1.93m
Revenue (TTM)	US$3.43m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is VSMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VSMD income statement (TTM)
Revenue	US$3.43m
Cost of Revenue	US$1.45m
Gross Profit	US$1.98m
Other Expenses	US$3.91m
Earnings	-US$1.93m

Last Reported Earnings

Jun 30, 2009

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did VSMD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 07:17
End of Day Share Price	2024/10/29 00:00
Earnings	2009/06/30
Annual Earnings	2008/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vasamed, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution